back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-05 12:37 Tx date 2024-01-14 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-17,325
-42 vol $412.50 each |
8,542 | |
| Filed 2023-12-26 11:27 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,627
+7,100 vol $0.37 each |
8,584 | |
| Filed 2022-12-19 15:27 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,495
+840 vol $1.78 each |
1,484 | |
| Filed 2022-10-12 18:20 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-18,181 vol |
758 | |
| Filed 2022-10-12 18:19 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-15,478 vol |
644 | |
| Filed 2022-01-24 12:44 Tx date 2022-01-24 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-30,303 vol |
16,122 | |
| Filed 2021-12-30 21:24 Tx date 2021-12-29 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,240
+7,000 vol $1.32 each |
46,425 | |
| Filed 2020-12-17 12:04 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
39,425 | |
| Filed 2020-12-03 16:19 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-606,061 vol |
18,939 | |
| Filed 2020-12-03 16:09 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,037,575 vol |
32,425 | |
| Filed 2020-01-20 16:19 Tx date 2020-01-12 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,750
+35,000 vol $0.25 each |
1,070,000 | |
| Filed 2019-01-16 Tx date 2019-01-14 |
$IN
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,500
+35,000 vol $0.50 each |
1,035,000 | |
| Filed 2016-11-01 Tx date 2016-10-20 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$50,000
+625,000 vol $0.08 each |
625,000 | |
| Filed 2016-11-01 Tx date 2016-09-12 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-10-03 Tx date 2016-09-12 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,000,000 |